#Israel #Haifa #Insightec #Exablate #MR-guided Ultrasound

Insightec Celebrates 10,000 Treated Patients

In a remarkable achievement for the field of medical technology, Insightec has announced that 10,000 patients across Europe, the Middle East, and Africa (EMEA) have been treated with its MR-guided focused ultrasound system, known as Exablate. This milestone underscores a substantial increase in treatment volumes, with reported numbers more than doubling in the past three years alone. The expansion of treatment options allows patients suffering from essential tremor and Parkinson's disease access to incisionless therapy at over 62 treatment centers across 20 countries.

A Transformative Approach to Patient Care

Insightec, a pioneer in the field of MR-guided focused ultrasound (MRgFUS), aims to transform patient care by providing non-invasive therapeutic options for those who previously had little choice but to rely on medication or undergo invasive surgery. The Exablate platform utilizes focused sound waves, precisely guided by MRI technology, to target problematic areas of the brain without incisions, making it a game-changer for many patients.

Jake Ghannam, Insightec's Executive Vice President and Chief Commercial Officer, highlighted the profound impact of this achievement: “Behind every one of those treatments is a person who got their life back—a hand steady enough to enjoy a cup of coffee or write a birthday card.” This sentiment resonates with many individuals whose daily lives have been significantly improved after receiving treatment.

Stories of Change

One such story is that of Juan José, a 56-year-old carpenter living in Spain, who has struggled with essential tremor since childhood. Years of living with this condition led him to shy away from social interactions out of embarrassment. Following successful treatment with MRgFUS, he expressed newfound confidence, stating, “Now I understand what life is like for normal people. I feel that I am in control of everything again.” This narrative illustrates the tangible, life-altering effects of Insightec's technology on real individuals.

Growing but Uneven Access

While the progress is commendable, it also highlights the disparities in access to advanced medical treatment within the EMEA region. Millions of individuals continue to live with conditions like essential tremor and Parkinson's disease, yet many are still unable to benefit from available therapies due to uneven access and reimbursement structures. The ability to receive focused ultrasound varies greatly depending on one's geographic location.

Maurice Ferré, MD, Chairman and CEO of Insightec, remarked, “Ten thousand patients is a milestone worth celebrating, but it also reminds us how much more there is to do. Where someone lives should not determine whether they can access an appropriate treatment option.” Insightec’s commitment goes beyond numbers; it aims to bridge the gap in care access for all patients.

A Vision for the Future

As Insightec continues its mission to enhance patient care, it is actively collaborating with health authorities, clinical societies, and patient advocacy groups. The goal is to establish sustainable treatment pathways in areas where access is limited. This initiative reflects a broader vision of equitable healthcare, where more patients can be treated annually across more countries.

In summary, Insightec's milestone of treating 10,000 patients is not just a statistic; it represents thousands of lives improved and stories of hope rejuvenated. As the company forges ahead in its quest for broader access to its innovative technology, the emphasis remains on making a meaningful difference in patient lives everywhere. With over 30,000 patients treated globally at 226 centers, Insightec is setting new benchmarks in non-invasive therapies and redefining patient care on an international scale.

• ---

For more information about Insightec and the transformative power of MR-guided focused ultrasound, visit insightec.com.